Advertisement

Ads Placeholder
Loading...

GABY Inc.

GABLF•PNK
Healthcare
Medical - Pharmaceuticals
$0.001
$0.00(45.00%)
U.S. Market opens in 49h 13m

GABY Inc. (GABLF) Stock Overview

Explore GABY Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.7M
P/E Ratio-0.04
EPS (TTM)$-0.04
ROE2.91%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

GABLF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of GABY Inc. (GABLF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.04 and a market capitalization of 2.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
-96.37%
5-Year Change
-99.37%
All-Time (Max) Change
-99.68%

Contact Information

https://www.gabyinc.com
NaN
200, 209-8th Avenue SW, Calgary, AB, T2P 1B8

Company Facts

IPO DateOct 29, 2018
CountryCA

Frequently Asked Questions